InsidersTradesSigma
Track the 金河生物 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 金河生物 has logged 3 insider filings. Market capitalisation: €3.7bn. The latest transaction was disclosed on 19 August 2025 (Sale). Among the most active insiders: 内蒙古金河控股有限公司. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
金河生物 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of biological products.